Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 3/20 | 0.33 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.33 |
| ▸ | CDC14B | O60729 | 2/20 | 0.32 |
| ▸ | CDC14A | Q9UNH5 | 2/20 | 0.32 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.30 |
| ▸ | TNKS | O95271 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25516241 | 1.00 | PLA2G2A (0.33) | PLA2G2APLA2G4ACDC14BCDC14APLA2G10 | |
| SCHEMBL25869569 | 0.94 | PLA2G2A (0.34) | PLA2G2APLA2G4ACDC14BCDC14APLA2G10 | |
| SCHEMBL23511932 | 0.93 | PGR (0.32) | PLA2G2APLA2G4ACDC14BCDC14APLA2G10 | |
| SCHEMBL25869554 | 0.93 | TDP1 (0.34) | — | |
| SCHEMBL25516451 | 0.92 | PLA2G2A (0.36) | PLA2G2APLA2G4ACDC14BCDC14APLA2G10 | |
| SCHEMBL24539801 | 0.91 | PLA2G2A (0.33) | PLA2G2APLA2G4ACDC14BCDC14APLA2G10 | |
| SCHEMBL26040251 | 0.91 | PLA2G2A (0.34) | PLA2G2APLA2G4ACDC14BCDC14APLA2G10 | |
| SCHEMBL25869433 | 0.91 | CDC14B (0.33) | PLA2G2APLA2G4ACDC14BCDC14APLA2G10 | |
| SCHEMBL25515816 | 0.91 | PLA2G2A (0.35) | PLA2G2APLA2G4ACDC14BCDC14APLA2G10 | |
| SCHEMBL25516235 | 0.90 | PLA2G2A (0.33) | PLA2G2APLA2G4ACDC14BCDC14AALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240215441-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2024-06-27 | — | — | US | disclosed |
| WO-2023132694-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2023-07-13 | — | — | WO | disclosed |
| WO-2023085881-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2023-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240215441-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY2, CRY1, AHR | PLA2G2A 2355/4885PLA2G4A 2625/4885CDC14B 3726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.